ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 804–811
DOI: 10.46882/AJIDR/149018
Article Type: Research Article
Title: Prevalence, phylogenetic diversity, and artemisinin partner drug resistance markers in Plasmodium vivax malaria
Names of Authors: Camila Morales¹*, Dawit Bekele², Haruka Sato³
Abstract: Plasmodium vivax poses distinct elimination challenges due to dormant hepatic hypnozoites and emerging resistance to chloroquine and antifolate drugs. We investigated pvmdr1 copy number variations, pvcrt-o expression, and microsatellite population structure among symptomatic vivax malaria patients. Venous blood samples from 295 microscopy-confirmed cases were analyzed via quantitative polymerase chain reaction and capillary electrophoresis. The pvmdr1 Y976F mutation was detected in 27.8 percent of isolates alongside high multiplicity of infection across endemic districts. Radical cure with primaquine or tafenoquine following glucose-6-phosphate dehydrogenase screening prevents relapses.
Keywords: Plasmodium vivax, Chloroquine resistance, Pvmdr1, Relapsing malaria, Molecular surveillance
Citation: Morales C, Bekele D, Sato H (2026). Prevalence, phylogenetic diversity, and artemisinin partner drug resistance markers in Plasmodium vivax malaria. African Journal of Infectious Diseases Research, 13(11): 804–811. DOI: 10.46882/AJIDR/149018
Manuscript Timeline: Received: September 15, 2026; Revised: October 16, 2026; Accepted: November 10, 2026; Published: November 16, 2026
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read